JOSHUA D LEE

Summary

Affiliation: New York University
Country: USA

Publications

  1. doi request reprint Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months
    JOSHUA D LEE
    New York University School of Medicine, NY, USA
    J Subst Abuse Treat 43:458-62. 2012
  2. pmc Buprenorphine-naloxone maintenance following release from jail
    JOSHUA D LEE
    Division of General Internal Medicine, New York University School of Medicine, New York, New York, USA
    Subst Abus 33:40-7. 2012
  3. pmc Working with patients with alcohol problems: a controlled trial of the impact of a rich media web module on medical student performance
    JOSHUA D LEE
    Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
    J Gen Intern Med 23:1006-9. 2008
  4. doi request reprint Substance use prevalence and screening instrument comparisons in urban primary care
    JOSHUA D LEE
    Division of General Internal Medicine, New York University School of Medicine, New York, New York 10010, USA
    Subst Abus 32:128-34. 2011
  5. doi request reprint Extended-release naltrexone for treatment of alcohol dependence in primary care
    JOSHUA D LEE
    New York University School of Medicine, New York, NY 10010, USA
    J Subst Abuse Treat 39:14-21. 2010
  6. pmc Home buprenorphine/naloxone induction in primary care
    JOSHUA D LEE
    New York University School of Medicine, New York, NY, USA
    J Gen Intern Med 24:226-32. 2009
  7. doi request reprint Teaching physicians to address unhealthy alcohol use: a randomized controlled trial assessing the effect of a Web-based module on medical student performance
    Andrea Truncali
    Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    J Subst Abuse Treat 40:203-13. 2011
  8. pmc Psychiatric Comorbidity, Red Flag Behaviors, and Associated Outcomes among Office-Based Buprenorphine Patients Following Hurricane Sandy
    Arthur R Williams
    New York University, New York City, NY, USA
    J Urban Health 91:366-75. 2014
  9. pmc Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
    Babak Tofighi
    Department of Population Health, New York University School of Medicine, 227 E, 30th St, 7th Floor, New York, NY 10016, USA
    Addict Sci Clin Pract 9:3. 2014
  10. pmc Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients
    Jennifer McNeely
    Department of Population Health and Department of Medicine, Division of General Internal Medicine, New York University School of Medicine, 550 1st Avenue, VZ30, 6th Floor, New York, NY 10016 Electronic address
    J Subst Abuse Treat 47:93-101. 2014

Collaborators

Detail Information

Publications13

  1. doi request reprint Extended-release naltrexone plus medical management alcohol treatment in primary care: findings at 15 months
    JOSHUA D LEE
    New York University School of Medicine, NY, USA
    J Subst Abuse Treat 43:458-62. 2012
    ..38% days abstinent; 11 vs. 61% heavy drinking days. Long-term XR-NTX treatment in a primary care MM model was feasible and may promote lasting drinking reductions or alcohol abstinence (clinical trial: NCT00620750)...
  2. pmc Buprenorphine-naloxone maintenance following release from jail
    JOSHUA D LEE
    Division of General Internal Medicine, New York University School of Medicine, New York, New York, USA
    Subst Abus 33:40-7. 2012
    ..Postrelease patients in primary care buprenorphine treatment had equal treatment retention and rates of opioid abstinence versus community-referred patients...
  3. pmc Working with patients with alcohol problems: a controlled trial of the impact of a rich media web module on medical student performance
    JOSHUA D LEE
    Division of General Internal Medicine, New York University School of Medicine, New York, NY, USA
    J Gen Intern Med 23:1006-9. 2008
    ..We designed an interactive web module to improve medical student competence in screening and interventions for hazardous drinking. We assessed its impact on performance with a standardized patient (SP) vs. traditional lecture...
  4. doi request reprint Substance use prevalence and screening instrument comparisons in urban primary care
    JOSHUA D LEE
    Division of General Internal Medicine, New York University School of Medicine, New York, New York 10010, USA
    Subst Abus 32:128-34. 2011
    ..The NIAAA single item correlated closely with alcohol ASSIST. TICS and EMR were less sensitive for any nontobacco substance use...
  5. doi request reprint Extended-release naltrexone for treatment of alcohol dependence in primary care
    JOSHUA D LEE
    New York University School of Medicine, New York, NY 10010, USA
    J Subst Abuse Treat 39:14-21. 2010
    ..1 (95% confidence interval = 2.9-6) at baseline to 0.5 (0-1.7) during Month 3. Extended-release naltrexone delivered in a primary care MM model appears a feasible and acceptable treatment for alcohol dependence...
  6. pmc Home buprenorphine/naloxone induction in primary care
    JOSHUA D LEE
    New York University School of Medicine, New York, NY, USA
    J Gen Intern Med 24:226-32. 2009
    ..We offered buprenorphine treatment at a public hospital primary care clinic using a home, unobserved induction protocol...
  7. doi request reprint Teaching physicians to address unhealthy alcohol use: a randomized controlled trial assessing the effect of a Web-based module on medical student performance
    Andrea Truncali
    Department of Medicine, New York University School of Medicine, New York, NY 10016, USA
    J Subst Abuse Treat 40:203-13. 2011
    ..The authors developed and evaluated an interactive, Web-based module to train medical students in screening and brief intervention (SBI) for unhealthy alcohol use...
  8. pmc Psychiatric Comorbidity, Red Flag Behaviors, and Associated Outcomes among Office-Based Buprenorphine Patients Following Hurricane Sandy
    Arthur R Williams
    New York University, New York City, NY, USA
    J Urban Health 91:366-75. 2014
    ..Additionally, patients endorsing new-onset psychiatric manifestations following disasters may be an especially high-risk group for poor outcomes, warranting further study. ..
  9. pmc Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy
    Babak Tofighi
    Department of Population Health, New York University School of Medicine, 227 E, 30th St, 7th Floor, New York, NY 10016, USA
    Addict Sci Clin Pract 9:3. 2014
    ....
  10. pmc Test-retest reliability of a self-administered Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in primary care patients
    Jennifer McNeely
    Department of Population Health and Department of Medicine, Division of General Internal Medicine, New York University School of Medicine, 550 1st Avenue, VZ30, 6th Floor, New York, NY 10016 Electronic address
    J Subst Abuse Treat 47:93-101. 2014
    ..90-0.97) for tobacco, alcohol, and drugs. The ACASI ASSIST has good test-retest reliability, and warrants additional study to evaluate its validity for detecting unhealthy substance use. ..
  11. pmc Undergraduate medical education in substance abuse: a review of the quality of the literature
    Devyani Kothari
    Substance Abuse Research and Education Training SARET Program, New York University School of Medicine, New York, New York, USA
    Acad Med 86:98-112. 2011
    ..To prepare to develop a medical school curriculum on substance abuse disorders (SADs), the authors conducted a review of the quality of the sparse published literature...
  12. doi request reprint Internet highs--seizures after consumption of synthetic cannabinoids purchased online
    Babak Tofighi
    Lenox Hill Hospital, 100 East 77th Street, New York, NY 10075, USA
    J Addict Med 6:240-1. 2012
    ..In addition, after reports in lay media of seizures and coma attributed to the consumption of the drug, anecdotal reports have emerged of similar findings in the medical literature...
  13. doi request reprint Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort
    Andiea Harris
    Prison Health Services, Inc, New York, New York, USA
    Subst Abus 33:70-5. 2012
    ..Patients who reached a moderate-to-high methadone dose demonstrated higher rates of reporting to community MTP versus lower doses, both pre- and post-QI. Overall, a higher proportion of all patients reported to community MTP post-QI...

Research Grants2

  1. Treatment Study Using Depot Naltrexone(3/6)NY/Bellevue Protocol Treatment Site
    JOSHUA D LEE; Fiscal Year: 2010
    ..The data from this study can also be used by the FDA to evaluate the benefits of this treatment that could improve the lives of patients suffering from opioid addiction. ..